➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Dow
Colorcon
Mallinckrodt
Medtronic

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

IPRATROPIUM BROMIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Ipratropium Bromide patents expire, and when can generic versions of Ipratropium Bromide launch?

Ipratropium Bromide is a drug marketed by Actavis Mid Atlantic, Apotex Inc, Aurobindo Pharma Ltd, Bausch And Lomb Inc, Landela Pharm, Mylan Speciality Lp, Nephron, Pharmascience Inc, Ritedose Corp, Roxane, Sun Pharm, Teva Pharms Usa, Watson Labs, Bausch And Lomb, and Hikma. and is included in twenty-one NDAs.

The generic ingredient in IPRATROPIUM BROMIDE is ipratropium bromide. There are eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ipratropium bromide profile page.

US ANDA Litigation and Generic Entry Outlook for Ipratropium Bromide

A generic version of IPRATROPIUM BROMIDE was approved as ipratropium bromide by RITEDOSE CORP on January 26th, 2001.

  Start Trial

Drug patent expirations by year for IPRATROPIUM BROMIDE
Drug Sales Revenue Trends for IPRATROPIUM BROMIDE

See drug sales revenues for IPRATROPIUM BROMIDE

Recent Clinical Trials for IPRATROPIUM BROMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rijnstate HospitalPhase 4
Theravance BiopharmaPhase 2
University of California, Los AngelesPhase 2

See all IPRATROPIUM BROMIDE clinical trials

Pharmacology for IPRATROPIUM BROMIDE
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Medical Subject Heading (MeSH) Categories for IPRATROPIUM BROMIDE

US Patents and Regulatory Information for IPRATROPIUM BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic IPRATROPIUM BROMIDE ipratropium bromide SOLUTION;INHALATION 075111-001 Apr 22, 1999 DISCN No No   Start Trial   Start Trial   Start Trial
Hikma IPRATROPIUM BROMIDE ipratropium bromide SPRAY, METERED;NASAL 076664-001 Nov 5, 2003 AB RX No Yes   Start Trial   Start Trial   Start Trial
Nephron IPRATROPIUM BROMIDE ipratropium bromide SOLUTION;INHALATION 075562-001 Sep 27, 2001 AN RX No No   Start Trial   Start Trial   Start Trial
Bausch And Lomb Inc IPRATROPIUM BROMIDE ipratropium bromide SOLUTION;INHALATION 075835-001 Oct 15, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa IPRATROPIUM BROMIDE ipratropium bromide SOLUTION;INHALATION 075313-001 Feb 7, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Speciality Lp IPRATROPIUM BROMIDE ipratropium bromide SPRAY, METERED;NASAL 075552-001 Mar 31, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmascience Inc IPRATROPIUM BROMIDE ipratropium bromide SOLUTION;INHALATION 075507-001 Jan 19, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Colorcon
Medtronic
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.